Bench2Market Talks
"Regulatory Strategy Without the Sticker Shock: What You Can DIY and What You Shouldn't" - Julie Byars, Ontogen MedTech
REGISTER HERE for participation link
Julie Byars
Principal, Co-Founder
Ontogen MedTech
Early navigation of regulatory pathways is complex, nuanced, important to get right, and critical to investment. Consequently, regulatory experts charge come of the highest rates in the industry. We’ll discuss ways to demystify your own regulatory pathway and engage regulatory experts in the right ways at the right time for your company.
The Bench2Market Talks series is created to provide commercialization guidance to the university research community. For more details on the series, visit our website.